ClinicalTrials.gov
ClinicalTrials.gov Menu

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00269438
Recruitment Status : Completed
First Posted : December 23, 2005
Last Update Posted : December 23, 2009
Sponsor:
Information provided by:
Valeant Pharmaceuticals International, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2007
  Actual Study Completion Date : June 2007